by Caroline Fife, M.D. | Dec 6, 2019 | Cellular / Tissue-Based Products, Fight the Good Fight, Healthcare Payment Policy
Re-printed from Today’s Wound Clinic We are at an important crossroads in the field of wound management. From the perspective of new technologies, the future is bright. Unfortunately, the future of the field itself is dismal. Under Medicare’s new Quality Payment...
by Caroline Fife, M.D. | Oct 10, 2019 | Cellular / Tissue-Based Products, Healthcare Payment Policy
Guest blog post by Dr. Helen Gelly Using the claims data from Medicare that are publicly available, a newly published study which I co-authored looked at various parameters that will eventually impact the bundled pricing payment model. Because a number of insurance...
by Caroline Fife, M.D. | Sep 18, 2019 | Cellular / Tissue-Based Products, Uncategorized
An increasing percentage of my wound center patients have Medicare Advantage plans offered by private payers. As I’ve discussed on previous blogs, it’s getting very hard to use cellular and/or tissue-based products (CTPs) on chronic wound patients with Medicare...
by Caroline Fife, M.D. | Jan 15, 2019 | Cellular / Tissue-Based Products, Fight the Good Fight, Health Information Technology and Wound Care, Quality Payment Program
Since clinicians were first offered a financial incentive to purchase and use an electronic health record (EHR) to obtain bonus money (or avoid penalties), they have been required to use only “certified EHR technology” (CEHRT). The names of the various payment...
